Myomo (NYSEAMERICAN:MYO) Director Heather Getz Acquires 70,000 Shares of Stock

Myomo, Inc. (NYSEAMERICAN:MYO) Director Heather Getz purchased 70,000 shares of the company’s stock in a transaction dated Thursday, March 12th. The shares were bought at an average price of $0.73 per share, for a total transaction of $51,100.00. Following the completion of the transaction, the director directly owned 111,754 shares in the company, valued at approximately $81,580.42. This trade represents a 167.65% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Myomo Stock Performance

Shares of NYSEAMERICAN MYO traded up $0.01 during mid-day trading on Friday, hitting $0.70. The company had a trading volume of 267,761 shares, compared to its average volume of 508,509. Myomo, Inc. has a 12 month low of $0.64 and a 12 month high of $5.62. The stock has a market cap of $27.07 million, a price-to-earnings ratio of -1.90 and a beta of 1.17. The company has a debt-to-equity ratio of 0.98, a current ratio of 3.30 and a quick ratio of 2.10. The firm’s 50 day simple moving average is $0.85 and its two-hundred day simple moving average is $0.92.

Analysts Set New Price Targets

A number of research firms recently weighed in on MYO. Craig Hallum reaffirmed a “buy” rating on shares of Myomo in a report on Tuesday. Ascendiant Capital Markets reduced their target price on shares of Myomo from $10.50 to $10.00 and set a “buy” rating for the company in a research note on Friday, November 21st. Four analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $7.67.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of MYO. Dynamic Technology Lab Private Ltd bought a new stake in shares of Myomo during the first quarter valued at about $75,000. Invesco Ltd. acquired a new position in Myomo during the 2nd quarter valued at about $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Myomo during the 2nd quarter valued at about $38,000. Intech Investment Management LLC bought a new stake in shares of Myomo during the 2nd quarter worth about $38,000. Finally, Acadian Asset Management LLC acquired a new stake in shares of Myomo in the 1st quarter worth approximately $114,000. Institutional investors own 44.99% of the company’s stock.

About Myomo

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.